background
banner

DERMA-T 1%

Active Substance: Clindamycin (as phosphate).

22
UAD , based on 7541 reviews.
View Drug details
Overview

Welcome to Dwaey, specifically on DERMA-T 1% Topical Solution page.
This medicine contains an important and useful components, as it consists of Clindamycin (as phosphate).
DERMA-T 1% is available in the market in concentration 10mg/ml and in the form of Topical Solution.

TABUK PHARMACEUTICAL MANUFACTURING CO. is the producer of DERMA-T 1% and it is imported from SAUDI ARABIA, The most popular alternatives of DERMA-T 1% are listed downward .

Mode Of Action & Indication

Clindamycin inhibits protein synthesis by reversibly binding to the 50S subunit of the ribosomal thus blocking the transpeptidation or translocation reactions of susceptible organisms resulting to stunted cell growth.

Indication
  • Dental infections
  • Respiratory tract infections
  • Skin and soft tissue infections
  • peritonitis
  • acne
  • anaerobic infections
  • endocarditis
  • Toxic shock syndrome
  • Bacterial vaginosis
  • Pelvic inflammatory disease
Precaution

Renal and hepatic diseases; pregnancy and lactation; GI disease; elderly, females, neonates, atopic patients. Regular monitoring of blood counts, liver and kidney functions. Lactation: Excreted in breast milk; manufacturer suggests discontinue drug or do not nurse (AAP Committee states compatible with nursing)

Side Effects
  • Diarrhoea
  • nausea
  • vomiting
  • abdominal pain; erythema multiforme
  • contact dermatitis
  • exfoliative and vesiculous dermatitis
  • urticaria; eosinophilia; local irritation
  • thrombophloebitis. Potentially Fatal: Gasping syndrome (neonates); pseudomembranous colitis.
Alternatives Price List
  • MEDACIN T 1%UAD 39
  • MEDACIN T 1%UAD 24
  • GLENCIN T 1%UAD 24
  • DERMA-T 1%UAD 22
  • DALACIN-C 900mg/6ml I.M/I.VUAD 40
Contra indication

Hypersensitivity.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Interaction

May enhance the action of neuromuscular blocking agents (e.g. atracurium). May antagonise the effects of parasympathomimetics. May competitively inhibit the effects of macrolides, ketolides, streptogramins, linezolid and chloramphenicol. Increased coagulation tests (prothrombin time/INR) and/or bleeding w/ vit K antagonists (e.g. warfarin, acenocoumarol, fluindione).

Releated Products

banner

Report Price Error

Please feel welcome to contact Us with any price or medical error. Our doctors will receive any reports.